Pre-tax profits at the main Irish arm of pharma giant Novartis more than doubled to €18.25m last year.

PRE-TAX profits at an Irish subsidiary of pharmaceutical giant Novartis last year increased by 41% to €11.9m.

PRE-TAX profits at the Irish sales arm of pharmaceutical company Novartis last year increased by 6% to €4.2 million.

PRE-TAX profits at an Irish subsidiary of pharmaceutical giant, Novartis last year dropped by 55% to €8.4 million.